drugset
Drugs / faecal human microbiota transplant (FMT)
last change Oct 2018 re-read 9 days ago

faecal human microbiota transplant (FMT)

Other / unclassified

Developed for
Clostridium infectious disease
Investigated by
Bacs-Kiskun Megyei Korhaz · Kenézy Gyula Korhaz es Rendelointezet · Miskolci Semmelweis Korhaz es Egyetemi Oktatokorhaz · Sejtterapia Kozpont Kft. · Szabolcs-Szatmar-Bereg Megyei Korhaz es Egyetemi Oktatokorhaz · UD-Genomed Kft.
+1 more · University of Debrecen

Trials 1

today NCT03053505 · not/applicable
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT03053505 Jan → Dec 2017 Clostridium infectious disease Sejtterapia Kozpont Kft. Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as faecal human microbiota transplant (FMT) ClinicalTrials.gov intervention name — accepted as the source's own label NCT03053505 ↗
Action Restore “the normal gut flora being restored by administering faecal homogenisate from a healthy donor” NCT03053505 ↗
Modality Other / unclassified “faecal microbiota transplantation (FMT)” NCT03053505 ↗